Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes.
about
Progresses towards safe and efficient gene therapy vectorsBarriers to inhaled gene therapy of obstructive lung diseases: A reviewRestoring ciliary function to differentiated primary ciliary dyskinesia cells with a lentiviral vector.Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length.Gene therapy finds its niche.Nanotechnology approaches for inhalation treatment of fibrosis.Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapyGenetic therapies for cystic fibrosis lung diseaseEfficient intratracheal delivery of airway epithelial cells in mice and pigsFerret and pig models of cystic fibrosis: prospects and promise for gene therapy.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.Advances in cell and gene-based therapies for cystic fibrosis lung diseaseGene therapy for the treatment of cystic fibrosis.Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors.Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapyCurrent status and future directions of gene and cell therapy for cystic fibrosis.Expert opinion in biological therapy: update on developments in lung gene transfer.New developments in lentiviral vector design, production and purification.Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.Assessment of selected media supplements to improve F/HN lentiviral vector production yields.Genetic medicines for CF: Hype versus reality.rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF modelRoadmap for an early gene therapy for cystic fibrosis airway disease.Validation of recombinant Sendai virus in a non-natural host model.Synchrotron phase-contrast X-ray imaging reveals fluid dosing dynamics for gene transfer into mouse airways.Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.Assessment of the nuclear pore dilating agent trans-cyclohexane-1,2-diol in differentiated airway epithelium.Assembly and Functional Analysis of an S/MAR Based Episome with the Cystic Fibrosis Transmembrane Conductance Regulator Gene.
P2860
Q26781432-C0B503DB-C7A7-423C-858E-0EB65D876205Q29248141-3B3109C7-D481-4EAA-B6EE-65D6BF6DAB2DQ30586012-9534126C-20F0-4484-9A87-C1F2CAC78CB6Q34000604-9EF3A134-1C49-4E7D-B282-F2459F54E43DQ34163207-CD88C476-1BEF-4AAD-A569-99882B75F19DQ34449624-7DBFA898-8C32-4B9C-A7AC-00DCAB808584Q34642249-7365A3E5-64A3-4568-9773-056CC851EC43Q34982862-FF2F81D7-1428-4C3C-96BD-C9A7102F762CQ35115851-7DF0084B-0AF8-4DDC-91B4-8D78DCEDF215Q35200182-5E6E5AE4-7325-4E5C-8A5C-A18C2EA97F86Q35641704-D0C0A714-9C63-4358-A224-B67605FFDD7EQ35659323-27FAD821-28E2-4FD0-B285-1B44B2AF7095Q36014033-7ECA2DD7-A5FB-4B85-8CCC-0A53534EA3EDQ36925241-F5CC44A8-8AA9-4F93-82D7-1D0E9A4209A9Q37265494-3B3FAB05-FE60-46F8-B5DE-89A305982A21Q37616952-9AA597B5-2E98-4909-9038-6C17F1E2A7E8Q37633995-F0F007BB-46BD-41A8-A1B7-A784B6B833BEQ37708026-488ACDE7-3621-4820-9855-6A8888D9F399Q37858512-6C428A6C-73ED-4D5B-A258-EC07C2A708CAQ38071683-F9063E2A-300F-41B6-908E-78E133E81526Q38099382-1CBAE191-0E30-40F1-A559-6EF97A518898Q38513773-5C622039-82AD-416F-B873-C64010115C02Q38693642-A5F024AE-7E8F-42DF-BB48-B90CF581A448Q38818339-26C180F3-D778-4205-BB63-293E91B3F153Q38949076-C59B1044-B91D-4FFD-BEA8-F30CAA48F8BCQ39166790-431EA452-5C4C-44A9-910E-CF6AF9D094CDQ39448490-50DAA5AB-975A-400F-B726-68CE95354646Q41923573-0C4B2ABE-C0CC-475B-8DFA-950AB6E3A671Q43930000-436353A7-48DC-4B03-8B52-EE873EC08E64Q45870784-E7956A9F-677F-4B73-9E5F-E844AEFE64C7Q45874266-27E57B13-A27C-4E88-A91D-58E13D046020Q45879842-7DC4D33C-65A7-4E0B-A7F1-BE57C5EB6821Q52577502-163F1256-583F-48C8-8D6F-43E08E65D21B
P2860
Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toward gene therapy for cystic ...... d with Sendai virus envelopes.
@ast
Toward gene therapy for cystic ...... d with Sendai virus envelopes.
@en
type
label
Toward gene therapy for cystic ...... d with Sendai virus envelopes.
@ast
Toward gene therapy for cystic ...... d with Sendai virus envelopes.
@en
prefLabel
Toward gene therapy for cystic ...... d with Sendai virus envelopes.
@ast
Toward gene therapy for cystic ...... d with Sendai virus envelopes.
@en
P2093
P2860
P921
P356
P1433
P1476
Toward gene therapy for cystic ...... ed with Sendai virus envelopes
@en
P2093
Charanjit Singh
Cuixiang Meng
Eiji Akiba
Eric W F W Alton
Felix Munkonge
Gad M Frankel
Katsuyuki Mitomo
Lucinda Somerton
Makoto Inoue
Mamoru Hasegawa
P2860
P304
P356
10.1038/MT.2010.13
P50
P577
2010-03-23T00:00:00Z